ENDRA Life Sciences Inc. issued common stock purchase warrants for 1,156,774 shares with a five-year exercise period starting May 27, 2026, to LHE LNG Holdings LLC. The warrant issuance represents a capital structure transaction typically used to raise capital or compensate strategic partners in biomedical companies.